INNAVIRVAX

innavirvax-logo

InnaVirVax is a privately-owned biopharmaceutical company dedicated to the development of a cutting edge discovery in the field of therapy/prevention and prognostic of AIDS and HIV infection, other infectious diseases, and new cancer therapies.

#SimilarOrganizations #People #Financial #Website #More

INNAVIRVAX

Social Links:

Industry:
Biotechnology Health Diagnostics Therapeutics

Founded:
2008-01-01

Address:
Évry, Ile-de-France, France

Country:
France

Website Url:
http://www.innavirvax.fr

Total Employee:
11+

Status:
Active

Contact:
33 1 80 85 60 83

Email Addresses:
[email protected]

Total Funding:
12.17 M USD

Technology used in webpage:
Domain Not Resolving


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

bionsil-logo

BiOnSil

BiOnSil developing diagnostic and theranostic kits for the diagnosis of drug resistance in colorectal cancer.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

hookipa-pharma-logo

Hookipa Pharma

Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.

valipharma-logo

ValiPharma

ValiPharma develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer.

Current Employees Featured

patrice-debre_image

Patrice Debre
Patrice Debre Founder and Scientific Advisor @ InnaVirVax
Founder and Scientific Advisor

Founder


patrice-debre_image

Patrice Debre

Investors List

karista_image

Karista

Karista investment in Series A - InnaVirVax

Official Site Inspections

http://www.innavirvax.fr

  • Host name: 104.247.81.52
  • IP address: 104.247.81.52
  • Location: Canada
  • Latitude: 43.6319
  • Longitude: -79.3716
  • Timezone: America/Toronto

Loading ...

More informations about "InnaVirVax"

InnaVirVax - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 33 1 80 85 60 83 InnaVirVax is a privately-owned biopharmaceutical company dedicated to the …See details»

PRE-IPO INNAVIRVAX - Societe.com

Dec 3, 2020 PRE-IPO INNAVIRVAX, société par actions simplifiée, au capital social de 409667,00 EURO, dont le siège social est situé au 36 RUE DE MONCEAU, 75008 PARIS, …See details»

Minka-Tx | LinkedIn

Minka-Tx | 82 followers on LinkedIn. Following several months of strategic review and heavy financial restructuring, Innavirvax is reborn as Minka Therapeutics with a new sense of …See details»

Santé : la PME francilienne InnaVirVax est le chef de file ... - Bpifrance

La PME chef de file de ce projet est InnaVirVax, société de biotechnologies localisée au Genopole® d’Evry (91) qui a développé une plateforme vaccinale dédiée à différentes …See details»

InnaVirVax Initiates Phase 2 Clinical Trial Evaluating VAC-3S, A ...

Dec 1, 2013 For more information, visit our newly launched website: www.innavirvax.fr . Contacts: In France for InnaVirVax: Milestones Press Relations Bruno ARABIAN Tel.: +33 1 …See details»

InnaVirVax progresse contre le sida avec son immunothérapie

Sep 10, 2015 C'est le troisième tour de table pour InnaVirVax. Basée à Evry, la société de biotechnologies, spécialisée dans l'immunothérapie du sida, a levé cet été 3,6 millions d'euros …See details»

Innavirvax S.A. - BioCentury Company Profiles - BCIQ

Aug 10, 2015 Innavirvax S.A. - BioCentury Company Profiles for the biopharma industrySee details»

PRE-IPO INNAVIRVAX (820538833), tous les établissements de …

Tous les établissements PRE-IPO INNAVIRVAX (820538833) : siège, établissements secondaires (RNCS), activités, adresses, tranche d'effectifs, actifs et fermés. MENU CommanderSee details»

Etablissements > PRE-IPO INNAVIRVAX - 75008 - Societe.com

PRE-IPO INNAVIRVAX à PARIS 8 (75008) : établissement siège (RNCS), activité, adresse, tranche d'effectif, nature de l'établissement, date de créationSee details»

Organization | InnaVirVax

InnaVirVax Report issue. For profit Phase 2. Founded: Very France (2008 ... Organization Overview. First Clinical Trial. 2012 NCT01549119. First Marketed Drug. None First NDA …See details»

Research programme: cancer and HIV biotherapies - InnaVirVax

InnaVirVax, a French privately-owned biopharmaceutical company, is developing biotherapies for the treatment of cancer and HIV infections. The cancer biotherapySee details»

InnaVirVax Raises €3.6M in Third Funding Round - FinSMEs

Jul 19, 2015 InnaVirVax, an Evry, a Paris biopark-based biopharmaceutical company specialized in research and development of therapeutic solutions for infectious and major …See details»

InnaVirVax Takes In €3.6M Funding - PitchBook

InnaVirVax, a biopharmaceutical company developing therapies for infectious and major chronic diseases, has completed a €3.6 million financing.Investors include FCPR CapDecisif 2, G1J …See details»

InnaVirVax va tester l'efficacité de son vaccin antisida

Jan 31, 2014 C'est le tout début de l'étude clinique de phase II de ce candidat vaccin antisida mis au point par InnaVirVax, qui va se dérouler sur plus de deux ans et inclure 90 malades …See details»

Toute l'actualité sur INNAVIRVAX avec CFNEWS - Page 1

Jul 8, 2015 Retrouvez tous les articles sur INNAVIRVAX avec Corporate Finance News (CFNEWS). CFNEWS CFNEWS IMMO CFNEWS INFRA; Offre d'essai. S'abonner. Se …See details»

InnaVirVax Receives $4.9M Series B - vcnewsdaily.com

Historical InnaVirVax's investors CapDecisif 2 and G1J Ile-de-France also participated in the round. This funding allows the company to pursue its development, and especially to conduct …See details»

InvVax 2025 Company Profile: Valuation, Funding & Investors

InvVax General Information Description. Developer of vaccine technology designed to develop breakthrough and patented vaccines. The company's technology provides a universal …See details»

InnaVirvax - Company Profile - Tracxn

Feb 24, 2025 InnaVirVax is dedicated to the discovery and development of immune based therapeutics of AIDS and HIV infection, other infectious diseases. Its lead product VAC-3S …See details»

InnaVirvax | Founders and Board of Directors - Tracxn

List of Founders and Board of members of InnaVirvax. List of Founders and Board of members of InnaVirvax Toggle navigation. Solutions. By Investment Industry. Venture Capital Funds …See details»

InnaVirvax | Funding & Investors - Tracxn

List of Funding Rounds and Investors of InnaVirvax. List of Funding Rounds and Investors of InnaVirvax Toggle navigation. Solutions. By Investment Industry. Venture Capital Funds …See details»

linkstock.net © 2022. All rights reserved